Health Manufacturing & Supply Chain

DENVER – – November 06, 2026 -- Global Healthcare Exchange (GHX) opened early registration for GHX Summit 2027, offering savings of more than $600 per registration through February 12, 2027. The event runs May 10-13, 2027, at Loews Arlington Hotel in Arlington, Texas.

Providers, suppliers, distributors, ERP and GPO partners and industry organizations are expected to attend. GHX also opened nominations for the 2026 GHXcellence Awards.

GHX builds Summit 2027 around customer ideas from 77 organizations

The program extends September's vibeGHX event, where providers and suppliers built AI-powered prototypes. Seventy-seven organizations took part, each bringing real workflow challenges. Select winning teams will present their ideas live at Summit, and attendees can join another vibeGHX event.

Atlanta and Wilmington, Del. – September 18, 2026 -- PSMA Connect, a national Healthcare Group Purchasing Organization, has formed a strategic alliance with HealthIQ Solutions to bundle volume-discounted medical supply contracts with turn-key remote patient care programs for providers nationwide.

Alliance pairs supply chain discounts with zero-cost remote monitoring rollouts

The partnership gives medical practices and health systems access to PSMA Connect's discounted manufacturer contracts covering medical-surgical supplies, capital equipment, pharmaceuticals and vaccines. Simultaneously, providers can deploy HealthIQ Solutions' Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Advanced Primary Care Management (APCM) programs with no upfront costs, using cellular- and Bluetooth-connected devices and automated compliance tracking.

Tucson – September 13, 2026 -- Delta Development Team (DDT) has launched BloodCOMM®, a cloud-based blood management platform designed to digitize and automate blood supply chain tracking for hospitals, blood centers, EMS agencies, and air medical providers.

Platform creates digital identity for every blood unit from collection to disposition

BloodCOMM® uses barcode scanning, AI-powered label recognition, and automated event tracking to monitor blood unit location, temperature, expiration status, inspections, transfers, and excursions throughout the product lifecycle. The system builds a digital cold chain of custody record, capturing patient identifiers, product details, and deviation history as events occur rather than reconstructing them from paper logs or spreadsheets after the fact.

Boston – September 08, 2026 -- TraceLink has integrated its Drug Supply Chain Security Act (DSCSA) compliance solution with Omnicell, Inc. (Nasdaq: OMCL) pharmacy inventory management systems, embedding serialized product verification and traceability directly into hospital medication receiving workflows.

Integration eliminates separate compliance tools during medication receiving

Hospital and health system pharmacies must currently verify, document, and incorporate medication shipments into inventory while resolving compliance exceptions through manual processes that run alongside operational systems. The new integration allows pharmacy teams to verify serialized products, access traceability data, resolve verification exceptions, and complete compliance reporting within Omnicell's central pharmacy inventory management workflows as medications are received.

San Diego – September 07, 2026 -- Lighteum Medical has appointed Gaurav Agarwal as Chief Executive Officer, effective August 31, 2026, bringing nearly 30 years of medtech leadership to the precision component manufacturer.

Agarwal joins with a track record of over $15 billion in M&A activity and $11 billion in private equity dispositions

Agarwal most recently served as President and CEO of PE-backed Capsa Healthcare, where he delivered more than 20% revenue and EBITDA growth within 18 months, completed two tuck-in acquisitions, and expanded the company into software and services. He previously led Vyaire Medical as President and CEO, and held senior roles at Acelity/KCI, Smith & Nephew, and GE Healthcare. At Acelity/KCI, he oversaw global commercial operations during a portfolio transformation that preceded the company's $6.725 billion sale to 3M.

SHERIDAN, WYOMING - April 13, 2026 - TekniPlex, a materials science company serving healthcare and consumer products markets, operates a global portfolio of engineering, R&D, and manufacturing sites spanning the United States, Mexico, Belgium, and beyond, positioning the company to deliver specialized packaging and tubing solutions at scale. The company's dual-market strategy - combining advanced medical materials with consumer packaging innovations - reflects a structural bet that engineered materials must simultaneously satisfy clinical performance requirements and sustainability mandates. With over 650 patents and a library of more than 250 materials, TekniPlex's technology depth underpins a reported 99% customer retention rate. Upcoming participation in CMEF 2026, Paris Packing Week 2026, and IPPE 2026 signals active commercial expansion across three distinct sectors simultaneously.

SHERIDAN, WYOMING - April 09, 2026 - Medtech supply chains across North America depend on the continued operation of the United States-Mexico-Canada Agreement, and a formal renewal keeps tariff predictability intact for the more than 650 medtech and health tech companies that AdvaMed represents - the majority of them small businesses.

Why USMCA matters to the medtech sector

The U.S. medtech industry spans manufacturing, research and development, and global healthcare delivery. Cross-border supply chains between the United States, Mexico, and Canada underpin both domestic production and the export leadership that U.S. medtech companies hold internationally. Without a stable trilateral trade framework, manufacturers face uncertainty in sourcing components, managing regulatory timelines, and forecasting capital investments.

SHERIDAN, WYOMING - January 01, 2026 - Platinum Equity says it has completed its acquisition of the Owens & Minor Products & Healthcare Services business, establishing the operation as a privately held standalone company focused on medical supply distribution for the acute care market in the United States.

SHERIDAN, WYOMING - December 03, 2025 - AGC Biologics is expanding its Cell Line Development Center of Excellence through a new partnership with ATUM, integrating the Leap-In Transposase® expression platform to help biopharma developers move monoclonal antibodies and complex next-generation biologics into the clinic faster and more cost-effectively.

New options for faster, more flexible cell line development

As pressure grows to launch high-value biologics at lower cost, drug sponsors are looking for cell line development (CLD) solutions that combine speed, robustness and scalability. AGC Biologics' collaboration with ATUM adds a modern transposase-based expression platform to its CLD toolkit, creating a menu of fit-for-purpose options for standard monoclonals, multi-specific antibodies and other complex molecules.

SHERIDAN, WYOMING - December 02, 2025 - A series of FDA findings at Novo Nordisk's Bloomington, Indiana, fill/finish facility is forcing biotechs to rethink their commercial manufacturing strategies, with Regeneron and Scholar Rock now accelerating alternative capacity plans to break regulatory logjams linked to the ex-Catalent site.

FDA scrutiny at Novo's Bloomington site triggers CRLs

The Bloomington plant, one of three former Catalent sites Novo acquired for $11 billion to support surging GLP-1 demand, has become a bottleneck rather than a release valve for some of its biopharma customers. As a CDMO hub, the facility provided fill/finish services for a range of partners, but repeated quality issues have resulted in an Official Action Indicated (OAI) classification and multiple complete response letters (CRLs) from the FDA.